CAS Number138926-19-9
SynonymsSodium trihydrogen (1-hydroxy-3-(methylpentylamino)propylidene)diphosphonate, monohydrate.; Phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1); Ibandronic acid monosodium salt monohydrate; Ibandronate sodium hydrate; Ibandronate sodium monohydrate; sodium,hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate,hydrate; BM 21.0955Na.H2O; (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonic acid sodium; Sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate hydrate (1:1:1); Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, monosodium salt, monohydrate; MFCD00912167; Ibandronate (Sodium Monohydrate)
Molecular FormulaC9H24NNaO8P2
Molecular Weight359.23
Purity98%
Boiling Point587.8ºC at 760 mmHg
Melting Point84ºC (dec)
AppearanceWhite crystalline powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 138926-19-9 |
| Catalog No. | 2A-9010881 |
| Chinese Name | 伊班膦酸钠 |
| Synonyms | Sodium trihydrogen (1-hydroxy-3-(methylpentylamino)propylidene)diphosphonate, monohydrate.; Phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1); Ibandronic acid monosodium salt monohydrate; Ibandronate sodium hydrate; Ibandronate sodium monohydrate; sodium,hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate,hydrate; BM 21.0955Na.H2O; (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonic acid sodium; Sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate hydrate (1:1:1); Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, monosodium salt, monohydrate; MFCD00912167; Ibandronate (Sodium Monohydrate) |
| Molecular Formula | C9H24NNaO8P2 |
| Molecular Weight | 359.23 |
| Purity | 98 |
| Boiling Point | 587.8ºC at 760 mmHg |
| Melting Point | 84ºC (dec) |
| Appearance | White crystalline powder |
| Storage Condition | -20°C Freezer |
| Application | Ibandronate sodium salt monohydrate is a highly active nitrogen-containing diphosphate and can be used for osteoporosis. |
| HTC | 2922199090 |
| SMILES | [Na+].[P](=O)([O-])(O)[C@]([P](=O)(O)O)(O)CCN(CCCCC)C.O |
| InChI | 1S/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1 |
| InChI Key | VBDRTGFACFYFCT-UHFFFAOYSA-M |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| MSDS | msds/10881_1_138926_19_9.pdf |
| Use of | Properties Name Ibandronate Sodium Monohydrate Synonym More Synonyms Ibandronate sodium Biological Activity Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Others References [1]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8. [2]. Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33. [3]. Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9. [4]. Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8. Chemical & Physical Properties Molecular Formula C9H24NNaO8P2 Exact Mass 359.087494 PSA 170.21000 LogP 0.87390 Safety Information Hazard Codes Xn: Harmful; Risk Phrases R40 Safety Phrases 22-36 HS Code 2922199090 Synthetic Route ibandronic acid CAS#:114084-78-5 Ibandronate sodium CAS#:138926-19-9 1-hydroxy-3-(N-... CAS#:1263180-40-0 Ibandronate sodium CAS#:138926-19-9 Sodium hydroxide CAS#:1310-73-2 ibandronic acid CAS#:114084-78-5 Ibandronate sodium CAS#:138926-19-9 Precursor & DownStream Precursor 4 CAS#:114084-78-5 ibandronic acid CAS#:1263180-40-0 1-hydroxy-3-(N-... CAS#:1330-43-4 Sodium tetraborate CAS#:127-09-3 Sodium acetate DownStream 0 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 30.0% |
| Transport Info | Product name: Summary 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Granisetron | 109889-09-0 | 2A-9010779 |
| Hydrocortisone | 50-23-7 | 2A-9010867 |
| Hydroxychloroquine sulfate | 747-36-4 | 2A-9010870 |
| Hydroxyprogesterone acetate | 302-23-8 | 2A-9010871 |
| Hydroxyprogesterone caproate | 630-56-8 | 2A-9010872 |
| IBUPROFEN USP | 15687-27-1 | 2A-0202344 |
| Idarubicin | 58957-92-9 | 2A-9010888 |
| Idarubicin Hydrochloride | 57852-57-0 | 2A-9010889 |
| Idarubicinol | 86189-66-4 | 2A-9010890 |
| Ifosfamide | 3778-73-2 | 2A-9010901 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS